Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia

Blood

Volumn 100, Issue 6, 2002, Pages 2087-2093

  Hansen, Ryan J ^a   Balthasar, Joseph P ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; THROMBOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG CLEARANCE; DRUG EFFECT; DRUG HALF LIFE; FEMALE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0037105368     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v100.6.2087.h81802002087_2087_2093     Document Type: Article

References (28)

1. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
2. Intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura in childhood and adolescence
3. Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases
4. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases
5. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin
6. Fc-depleted vs intact intravenous immunoglobulin in chronic ITP
7. Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin
8. In-vitro inhibition of anti-platelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins
9. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
10. Correlation of in vitro antibody synthesis with the outcome of intravenous gamma-globulin treatment of chronic idiopathic thrombocytopenic purpura
11. High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance
12. Effects of high-dose intravenous gammaglobulin on kinetic parameters of 51Cr-labelled platelets in chronic ITP
13. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: A quantitative rat model of immune thrombocytopenic purpura
14. An ELISA for quantification of murine IgG in rat plasma: Application to the pharmacokinetic characterization of AP-3, a murine anti-glycoprotein IIIa monoclonal antibody, in the rat
15. Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin
16. Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: Results of a randomized trial comparing 0.5 and 1 g/kg b.w.
17. Soluble CD4 antigen reactivity in intravenous immunoglobulin preparations: Is it specific?
18. A theoretical model of gamma-globulin catabolism
19. 2-microglobulin-containing neonatal intestinal transport receptor
20. Mechanism of intravenous immune globulin therapy in antibody-mediated auto-immune diseases
21. FcRn: The MHC class I-related receptor that is more than an IgG transporter
22. Turnover of the plasma proteins
23. Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg
24. Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gamma-globulin therapy in patients with idiopathic thrombocytopenic purpura
25. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype
26. Transfer of anti-D antibodies across the isolated perfused human placental lobule and inhibition by high-dose intravenous immunoglobulin: A possible mechanism of action
27. The mode of action of treatment by IgG of haemolytic anaemia induced by an anti-erythrocyte monoclonal antibody
28. Treatment of Guillain-Barre syndrome with intravenous immunoglobulin